Cresset Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cresset Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.85M	Sell	139,069 -12,993	-9%	-$414K	0.02%	379
2026 Q1	$4.02M	Buy	152,062 +20,939	+16%	+$613K	0.02%	410
2025 Q4	$3.8M	Buy	131,123 +12,535	+11%	+$376K	0.02%	412
2025 Q3	$3.29M	Buy	118,588 +46,108	+64%	+$1.17M	0.01%	427
2025 Q2	$1.76M	Buy	72,480 +714	+1%	+$15.6K	0.01%	530
2025 Q1	$1.49M	Buy	71,766 +51,636	+257%	+$1.3M	0.01%	636
2024 Q4	$474K	Sell	20,130 -3,696	-16%	-$91K	﹤0.01%	1112
2024 Q3	$610K	Sell	23,826 -2,105	-8%	-$53.6K	﹤0.01%	1410
2024 Q2	$609K	Sell	25,931 -2,077	-7%	-$52.4K	﹤0.01%	1349
2024 Q1	$806K	Sell	28,008 -2,460	-8%	-$74K	﹤0.01%	1089
2023 Q4	$1,000K	Sell	30,468 -192	-0.6%	-$5.22K	0.01%	893
2023 Q3	$854K	Sell	30,660 -121	-0.4%	-$3.96K	﹤0.01%	928
2023 Q2	$1.05M	Buy	+30,781	New	+$967K	﹤0.01%	921
2022 Q3	–	Sell	-12,296	Closed	-$387K	–	885
2022 Q2	$387K	Sell	12,296 -133	-1%	-$4.65K	﹤0.01%	635
2022 Q1	$571K	Buy	12,429 +2,122	+21%	+$101K	0.01%	565
2021 Q4	$631K	Buy	10,307 +3,658	+55%	+$253K	0.01%	618
2021 Q3	$497K	Buy	6,649 +1,210	+22%	+$102K	0.01%	623
2021 Q2	$503K	Sell	5,439 -3,069	-36%	-$261K	0.01%	550
2021 Q1	$755K	Buy	8,508 +2,910	+52%	+$289K	0.01%	365
2020 Q4	$522K	Buy	5,598 +509	+10%	+$40.6K	0.01%	383
2020 Q3	$324K	Hold	5,089	–	–	0.01%	489
2020 Q2	$265K	Buy	+5,089	New	+$218K	0.01%	505
2019 Q2	–	Sell	-250	Closed	-$8K	–	555
2019 Q1	$8K	Buy	+250	New	+$7.38K	﹤0.01%	1222

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cresset Asset Management's ARKG Position: Q2 2026 in Review

Cresset Asset Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 8.5% in Q2 2026, selling an estimated $414K and leaving 139,069 shares worth $5.85M. The position accounts for 0.02% of the portfolio, ranked #379.

Cresset Asset Management first reported a position in ARKG in Q1 2019 and has held it in 23 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Cresset Asset Management held 139,069 shares of ARK Genomic Revolution ETF worth $5.85M as of Q2 2026.
Cresset Asset Management sold 12,993 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $414K.
ARK Genomic Revolution ETF made up 0.02% of Cresset Asset Management's portfolio in Q2 2026, its #379 holding.
Cresset Asset Management first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 23 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.